Resmed Inc
Change company Symbol lookup
Select an option...
RMD Resmed Inc
JACK Jack in the Box Inc
NH NantHealth Inc
PWSC PowerSchool Holdings Inc
AEHL Antelope Enterprise Holdings Ltd
POR Portland General Electric Co
CUBI Customers Bancorp Inc
MITT AG Mortgage Investment Trust Inc
UP Wheels Up Experience Inc
MBGAF Mercedes Benz Group AG
Go

Health Care : Health Care Equipment & Supplies | Mid Cap Growth
Company profile

ResMed Inc. is a holding company. The Company, through its subsidiaries, is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep-disordered breathing (SDB), chronic obstructive pulmonary disease (COPD), neuromuscular disease and other chronic diseases. The Company operates through two segments: Sleep and Respiratory Care segment, and the Software-as-a-Service (SaaS) segment. Sleep apnea includes obstructive sleep apnea and other respiratory disorders that occur during sleep. Its cloud-based digital health applications, along with its devices, are designed to provide connected care to improve patient outcomes. The Company's portfolio of products includes ventilation devices, diagnostic products, mask systems, headgear and other accessories, dental devices and cloud-based software informatics solutions.

Price
Delayed
$228.96
Day's Change
-2.80 (-1.21%)
Bid
--
Ask
--
B/A Size
--
Day's High
231.53
Day's Low
228.84
Volume
(Light)

Today's volume of 41,449 shares is on pace to be much lighter than RMD's 10-day average volume of 415,764 shares.

41,449

Display:

Providers:

UpdateCancel
6 providers
September 07, 2022
ResMed Announces Participation in the Bank of America Global Healthcare Conference

EQNX::TICKER_START (NYSE:RMD),(AUST:RMD.AX), EQNX::TICKER_END ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a fireside chat at the Bank of America Global Healthcare Conference on Wednesday...(Globe Newswire)

September 06, 2022
ResMed Announces Participation in the 20th Annual Morgan Stanley Global Healthcare Conference

EQNX::TICKER_START (NYSE:RMD),(AUST:RMD.AX), EQNX::TICKER_END ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will participate in a fireside chat at the 20 Annual Morgan Stanley Global Healthcare...(Globe Newswire)

September 04, 2022
Over 480 Million People Estimated to Have COPD, World's Third Deadliest Disease, ResMed Study Reports

EQNX::TICKER_START (NYSE:RMD),(AUST:RMD.AX), EQNX::TICKER_END Over 480 million people worldwide likely suffer from chronic obstructive pulmonary disease, or COPD, according to a late-breaking abstract led by ResMed (NYSE: RMD, ASX: RMD) presented at...(Globe Newswire)

August 11, 2022
ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2022

Note: A webcast of ResMed's conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com ResMed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended June 30, 2022. (Globe Newswire)

August 02, 2022
ResMed Acquires Leipzig-based mementor with Insomnia Digital Health Solution somnio

EQNX::TICKER_START (NYSE:RMD),(AUST:RMD.AX), EQNX::TICKER_END -- Acquisition lays foundation to build ResMed's digital sleep medicine portfolio in Germany -- somnio digital health application focused on improving sleep in patients with diagnosed...(Globe Newswire)

July 14, 2022
ResMed to Report Fourth Quarter Fiscal 2022 Earnings on August 11, 2022

EQNX::TICKER_START (NYSE:RMD),(AUST:RMD.AX), EQNX::TICKER_END ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2022 on Thursday, August 11, 2022, after the New...(Globe Newswire)

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.